• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎的小鼠模型:饮食模型的直接比较及其对炎症和动物福利的影响

Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare.

作者信息

Kroh Andreas, Ivanova Vanina, Drescher Hannah, Andruszkow Julia, Longerich Thomas, Nolting Jochen, Eickhoff Roman, Heise D, Rheinwalt Karl P, Neumann Ulf P, Ulmer Florian T

机构信息

Department of General, Visceral and Transplantation Surgery, RWTH Aachen University Hospital, 52074 Aachen, Germany.

Department of Internal Medicine III, RWTH Aachen University Hospital, 52074 Aachen, Germany.

出版信息

Gastroenterol Res Pract. 2020 Jul 13;2020:7347068. doi: 10.1155/2020/7347068. eCollection 2020.

DOI:10.1155/2020/7347068
PMID:32765601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7374209/
Abstract

A variety of dietary nonalcoholic steatohepatitis (NASH) mouse models are available, and choosing the appropriate mouse model is one of the most important steps in the design of NASH studies. In addition to the histopathological and metabolic findings of NASH, a sufficient mouse model should guarantee a robust clinical status and good animal welfare. Three different NASH diets, a high-fat diet (HFD60), a western diet (WD), and a cafeteria diet (CAFD), were fed for 12 or 16 weeks. Metabolic assessment was conducted at baseline and before scheduled sacrifice, and liver inflammation was analyzed via fluorescence-associated cell sorting and histopathological examination. Clinical health conditions were scored weekly to assess the impact on animal welfare. The HFD60 and WD were identified as suitable NASH mouse models without a significant strain on animal welfare. Furthermore, the progression of inflammation and liver fibrosis was associated with a decreased proportion of CD3 NK1.1 cells. The WD represents a model of advanced-stage NASH, and the HFD60 is a strong model of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. However, the CAFD should not be considered a NASH model.

摘要

有多种饮食诱导的非酒精性脂肪性肝炎(NASH)小鼠模型可供使用,选择合适的小鼠模型是NASH研究设计中最重要的步骤之一。除了NASH的组织病理学和代谢结果外,一个充分的小鼠模型应保证良好的临床状态和动物福利。给小鼠喂食三种不同的NASH饮食,即高脂饮食(HFD60)、西方饮食(WD)和自助餐厅饮食(CAFD),持续12周或16周。在基线和预定处死前进行代谢评估,并通过荧光相关细胞分选和组织病理学检查分析肝脏炎症。每周对临床健康状况进行评分,以评估对动物福利的影响。HFD60和WD被确定为合适的NASH小鼠模型,对动物福利没有显著影响。此外,炎症和肝纤维化的进展与CD3 NK1.1细胞比例的降低有关。WD代表晚期NASH模型,HFD60是一种强大的非酒精性脂肪性肝病(NAFLD)和代谢综合征模型。然而,CAFD不应被视为NASH模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/518a9aec14c1/GRP2020-7347068.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/59b075b53c8d/GRP2020-7347068.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/cc27a35cb166/GRP2020-7347068.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/a06bbd11aecd/GRP2020-7347068.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/a196180b9fbe/GRP2020-7347068.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/518a9aec14c1/GRP2020-7347068.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/59b075b53c8d/GRP2020-7347068.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/cc27a35cb166/GRP2020-7347068.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/a06bbd11aecd/GRP2020-7347068.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/a196180b9fbe/GRP2020-7347068.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ff6/7374209/518a9aec14c1/GRP2020-7347068.005.jpg

相似文献

1
Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare.非酒精性脂肪性肝炎的小鼠模型:饮食模型的直接比较及其对炎症和动物福利的影响
Gastroenterol Res Pract. 2020 Jul 13;2020:7347068. doi: 10.1155/2020/7347068. eCollection 2020.
2
Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.二十二碳六烯酸可阻断西式饮食诱导的肥胖Ldlr-/-小鼠非酒精性脂肪性肝炎的进展。
PLoS One. 2017 Apr 19;12(4):e0173376. doi: 10.1371/journal.pone.0173376. eCollection 2017.
3
Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?西方饮食诱导的Ldlr-/-小鼠非酒精性脂肪性肝炎是否可逆?
PLoS One. 2016 Jan 13;11(1):e0146942. doi: 10.1371/journal.pone.0146942. eCollection 2016.
4
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.利拉鲁肽可改善非酒精性脂肪性肝炎 3 周饮食诱导的小鼠模型中的肝脂肪变性和代谢功能障碍。
Am J Physiol Gastrointest Liver Physiol. 2019 Oct 1;317(4):G508-G517. doi: 10.1152/ajpgi.00139.2019. Epub 2019 Aug 28.
5
The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH).不同脂肪来源对非酒精性脂肪性肝炎(NASH)西方饮食小鼠模型中脂肪性肝炎和肝纤维化发展的影响
Front Physiol. 2019 Jun 25;10:770. doi: 10.3389/fphys.2019.00770. eCollection 2019.
6
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.FATZO小鼠是2型糖尿病的下一代模型,在喂食添加了果糖的西式饮食时会发展为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)。
BMC Gastroenterol. 2019 Mar 18;19(1):41. doi: 10.1186/s12876-019-0958-4.
7
A new method to induce nonalcoholic steatohepatitis (NASH) in mice.一种诱导小鼠非酒精性脂肪性肝炎(NASH)的新方法。
BMC Gastroenterol. 2019 Jul 15;19(1):125. doi: 10.1186/s12876-019-1041-x.
8
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.利拉鲁肽、奥贝胆酸和 Elafibranor 在经活检证实的非酒精性脂肪性肝炎肥胖小鼠模型中的代谢和肝脏作用。
World J Gastroenterol. 2018 Jan 14;24(2):179-194. doi: 10.3748/wjg.v24.i2.179.
9
Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.饱和脂肪和胆固醇对于引发伴有严重非酒精性脂肪性肝炎的小鼠代谢综合征至关重要。
J Nutr Biochem. 2015 Mar;26(3):285-92. doi: 10.1016/j.jnutbio.2014.11.002. Epub 2014 Dec 6.
10
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.在小鼠的高脂肪-高胆固醇-高糖饮食模型中,非酒精性脂肪变性进展为脂肪性肝炎和肝纤维化与促进炎症和肝肿瘤的危险信号的累积平行。
J Transl Med. 2015 Jun 16;13:193. doi: 10.1186/s12967-015-0552-7.

引用本文的文献

1
Sleeve-gastrectomy results in improved metabolism and a massive stress response of the liver proteome in a mouse model of metabolic dysfunction-associated steatohepatitis.在代谢功能障碍相关脂肪性肝炎小鼠模型中,袖状胃切除术可改善代谢并引发肝脏蛋白质组的巨大应激反应。
Heliyon. 2024 Sep 28;10(21):e38678. doi: 10.1016/j.heliyon.2024.e38678. eCollection 2024 Nov 15.
2
Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet.与等热量的西方饮食相比,高热量低碳水化合物高脂肪饮食可预防肥胖小鼠非酒精性脂肪性肝病的发生。
Front Nutr. 2024 Mar 20;11:1366883. doi: 10.3389/fnut.2024.1366883. eCollection 2024.
3

本文引用的文献

1
Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice.长期高脂饮食喂养会促进小鼠非酒精性脂肪性肝病的发展并改变其肠道微生物群。
World J Hepatol. 2019 Aug 27;11(8):619-637. doi: 10.4254/wjh.v11.i8.619.
2
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的小鼠模型:迈向优化其与人类非酒精性脂肪性肝炎相关性。
Hepatology. 2019 May;69(5):2241-2257. doi: 10.1002/hep.30333.
3
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.
Clinical characterization of a hypersensitivity mixed bacterial and fungal dermatitis in a translational model of porcine NASH.
猪非酒精性脂肪性肝炎模型中一种过敏反应性混合细菌和真菌感染性皮炎的临床特征。
Front Cell Infect Microbiol. 2024 Jan 24;13:1277045. doi: 10.3389/fcimb.2023.1277045. eCollection 2023.
4
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC.mTOR 在肝细胞中的缺失会加重非酒精性脂肪性肝炎相关 HCC 的肿瘤负担。
Neoplasia. 2023 Dec;46:100945. doi: 10.1016/j.neo.2023.100945. Epub 2023 Nov 15.
5
Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma.α1-钠钾 ATP 酶信号体在 NASH 相关肝细胞癌中的抑瘤作用。
Int J Mol Sci. 2022 Jul 1;23(13):7359. doi: 10.3390/ijms23137359.
非酒精性脂肪性肝病/非酒精性脂肪性肝炎的全球流行病学:我们未来的需求。
Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643.
4
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature.非酒精性脂肪性肝炎的小鼠模型:对近期文献的反思。
J Gastroenterol Hepatol. 2018 Jul;33(7):1312-1320. doi: 10.1111/jgh.14122. Epub 2018 Mar 24.
5
To Group or Not to Group? Good Practice for Housing Male Laboratory Mice.分组还是不分组?雄性实验小鼠饲养的良好做法。
Animals (Basel). 2017 Nov 24;7(12):88. doi: 10.3390/ani7120088.
6
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
7
Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.遗传 Nrf2 过激活可抑制肝细胞特异性 c-met 缺失在 NASH 进展过程中引起的有害影响。
Oxid Med Cell Longev. 2017;2017:3420286. doi: 10.1155/2017/3420286. Epub 2017 Jun 6.
8
Recommendation for severity assessment following liver resection and liver transplantation in rats: Part I.大鼠肝切除和肝移植后严重程度评估建议:第一部分。
Lab Anim. 2016 Dec;50(6):459-467. doi: 10.1177/0023677216678018.
9
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的多重打击发病机制。
Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4.
10
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.非酒精性脂肪性肝炎的动物模型:进食、清除与炎症
Dig Dis Sci. 2016 May;61(5):1325-36. doi: 10.1007/s10620-015-3977-1. Epub 2015 Dec 1.